Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
426. Mitchison DA. Natural sensitivity of M. tuberculosis to thiacetazone. Tubercle<br />
1968; 49 (suppl): 38-46.<br />
427. Grosset J, Rodrigues F, Benhassine M, Chaulet P, Larbaoui D. Sensitivity to<br />
thiacetazone of strains of Mycobacterium tuberculosis isolated in Algiers: practical<br />
deductions. Tubercle 1968; 49 (suppl): 46-8.<br />
428. Gangadharam PRJ, Devaki V, Mohan K. Thiacetazone sensitivity of Indian tubercle<br />
bacilli. Tubercle 1968; 49 (suppl): 48-51.<br />
429. Hamre D, Bernstein J, Donovick R. The chemotherapy of experimental tuberculosis.<br />
II. Thiosemicarbazones <strong>and</strong> analogues in experimental tuberculosis in<br />
the mouse. J Bacteriol 1950; 59: 675-80.<br />
430. Protivinsky R. Chemotherapeutics with tuberculostatic action. Antibiotics<br />
Chemother 1971; 17: 101-21.<br />
431. Liebermeister K. Zur Wirkung der tuberkulostatischen Chemotherapeutika.<br />
Deutsch Med Wschr 1950; 75: 621-2.<br />
432. Wernitz W, Tornus H. Quantitative Contebenstudien. IV. Mitteilung.<br />
Contebenblutspiegel beim Menschen. Zeitschr Klin Med 1952; 150: 170-6.<br />
433. Heilmeyer I, Heilmeyer L. Ueber Resorption und Ausscheidung von TBI 698<br />
(Conteben) nach peroraler Belastung. Klin Wochenschr 1949; 27: 790-1.<br />
434. Jenner PJ, Ellard GA, Swai OB. A study of thiacetazone blood levels <strong>and</strong> urinary<br />
excretion in man, using high per<strong>for</strong>mance liquid chromatography.<br />
1984; 55: 121-8.<br />
Lepr Rev<br />
435. Hinshaw HC, McDermott W. Thiosemicarbazone therapy of tuberculosis in<br />
humans. Am Rev Tuberc 1950; 61: 145-57.<br />
436. Miller AB.<br />
54-6.<br />
Thiacetazone toxicity: a general review. Tubercle 1968; 49 (suppl):<br />
437. Aquinas M. Side effects <strong>and</strong> toxicity to thiacetazone <strong>and</strong> isoniazid: findings in<br />
a Hong Kong <strong>Tuberculosis</strong> Treatment Service / British Medical Research Council<br />
investigation. Tubercle 1968; 49 (suppl): 56-8.<br />
438. Aquinas M. Side effects <strong>and</strong> toxicity in the combined regimen of thiacetazone<br />
<strong>and</strong> isoniazid in Morocco. Tubercle 1968; 49 (suppl): 58-9.<br />
439. Miller AB, Fox W, Tall R. An international co-operative investigation into thiacetazone<br />
(thioacetazone) side effects. Tubercle 1966; 47: 33-74.<br />
440. Stühmer A. Nebenerscheinungen bei der Beh<strong>and</strong>lung von Lupuskranken mit Tb<br />
I 698. Med Klin 1949; 27: 864-6.<br />
441. Raviglione MC, Dinan WA, Pablos-Mendez A, Palagiano A, Sabatini MT. Fatal<br />
toxic epidermal necrolysis during prophylaxis with pyrimethamine <strong>and</strong> sulfadoxine<br />
in a human immunodeficiency virus-infected person.<br />
2683-4.<br />
Arch Intern Med 1988;148:<br />
442. Senneville E, Lecocq P, Ajana F, Chidiac C, Mouton Y. Co-trimoxazole <strong>for</strong><br />
toxic epidermal necrolysis in AIDS. (Correspondence). Lancet 1991; 337: 919.<br />
197
Change language